Filing search / Centessa Pharmaceuticals plc / "Corporate Governance"

Search information

Centessa Pharmaceuticals plc

Companies

"Corporate Governance"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

27 results

Newest first Best match first

10-Q

2024 Q2

CNTA Centessa Pharmaceuticals plc

Quarterly report

establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010 … , the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”), was enacted. There are significant corporate governance and executive

13 Aug 24

7:27am

DEFA14A

CNTA Centessa Pharmaceuticals plc

20 May 24

Additional proxy soliciting materials

8:48pm

the Oberland Capital financing agreement. Corporate Governance Report (Section 172(1), Companies Act 2006 Statement) The directors of Centessa, and all … high standards for the Company’s employees, officers and Directors. Implicit in this philosophy is the importance of sound corporate governance

10-Q

2024 Q1

CNTA Centessa Pharmaceuticals plc

Quarterly report

, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further … , in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”), was enacted. There are significant corporate governance

13 May 24

4:32pm

DEF 14A

CNTA Centessa Pharmaceuticals plc

Definitive proxy

OF ALLOTMENT OF SHARES PROPOSAL 10 — DISAPPLICATION OF PREEMPTIVE RIGHTS BOARD OF DIRECTORS AND CORPORATE GOVERNANCE SECURITY OWNERSHIP OF CERTAIN … . For biographical information for the other directors, see Board of Directors and Corporate Governance. PROPOSAL 1 — RE-APPOINTMENT OF FRANCESCO DE

9 May 24

8:00am

PRE 14A

CNTA Centessa Pharmaceuticals plc

26 Apr 24

Preliminary proxy

4:36pm

-AUTHORIZATION OF ALLOTMENT OF SHARES PROPOSAL 10-DISAPPLICATION OF PREEMPTIVE RIGHTS BOARD OF DIRECTORS AND CORPORATE GOVERNANCE SECURITY OWNERSHIP … to our Board of Directors. For biographical information for the other directors, see Board of Directors and Corporate Governance. PROPOSAL 1-RE

10-K

p6yxd9bj 3kvhrzg2u

Annual report

28 Mar 24

4:44pm

10-Q

x4cms1 xlast2ze34

Quarterly report

13 Nov 23

4:22pm

10-Q

pc2lipwisb1og61 5lz

Quarterly report

14 Aug 23

7:18am

DEFA14A

unyzyf

23 May 23

Additional proxy soliciting materials

15 May 23

8:01am

10-Q

qkerc01u g1pbhu

Quarterly report

12 May 23

7:14am

10-K

g6vj 6fshvpokn2

Annual report

30 Mar 23

7:44am

10-Q

czkcn1w5klkqjy

Quarterly report

10 Nov 22

7:09am

10-Q

ckrslahdp0uceeea nu

Quarterly report

10 Aug 22

12:00am

8-K

mit2ckm

1 Jul 22

Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven

Additional proxy soliciting materials

16 May 22

7:41am

10-K/A

oph81p5b8rihxwbb

Annual report (amended)

2 May 22

4:30pm

Filing search / Centessa Pharmaceuticals plc / "Corporate Governance"

27 results

Top filers

Top filing types

Recent filing years